Literature DB >> 10428302

Downregulation by tumor necrosis factor-alpha of monocyte CCR2 expression and monocyte chemotactic protein-1-induced transendothelial migration is antagonized by oxidized low-density lipoprotein: a potential mechanism of monocyte retention in atherosclerotic lesions.

C Weber1, G Draude, K S Weber, J Wübert, R L Lorenz, P C Weber.   

Abstract

The subintimal infiltration with monocytes is crucially involved in the development of complex atherosclerotic plaques. Monocyte chemotactic protein-1 (MCP-1) and its receptor CCR2 are important for monocyte extravasation and formation of atherosclerotic lesions. However, mechanisms of monocyte persistence in atherosclerotic plaques remain to be elucidated. Flow cytometric analysis revealed that monocytoid Mono Mac 6 cells that had transmigrated endothelium towards a MCP-1 gradient expressed higher levels of CCR2 than the non-migratory fraction, while input cells were intermediate, suggesting that high CCR2 levels are essential for transendothelial chemotaxis. Pretreatment of Mono Mac 6 cells or isolated human blood monocytes with the inflammatory cytokine tumor necrosis factor (TNF)-alpha dose- and time-dependently reduced MCP-1-induced transendothelial chemotaxis, which was inhibited by the CCR2 receptor antagonist 9-76 analog. This was paralleled by a decrease in CCR2 surface protein and mRNA expression. as assessed by flow cytometry and reverse transcription-polymerase chain reaction, inferring that inhibition of monocyte transmigration was due to downregulation of CCR2 to levels insufficient for chemotaxis. In contrast, treatment of monocytes with oxidized low-density protein (oxLDL) containing oxidized lipids, such as cholesteryl linoleate 13-hydroxide. but not with LDL, increased CCR2 protein and mRNA expression. Notably, oxLDL counteracted the TNF-alpha-mediated downregulation of CCR2 and CCR2-dependent transendothelial chemotaxis. Macrophage-colony-stimulating factor hardly affected CCR2 expression and function, suggesting that differentiation was not responsible for effects on CCR2. In conclusion, TNF-alpha impairs MCP-1-induced transendothelial migration of monocytes by downregulating CCR2 which appears critical for migration. Exposure to oxLDL antagonized the effects of TNF-alpha, and may thus contribute to monocyte retention and perpetuation of a chronic inflammatory reaction in unstable atherosclerotic lesions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10428302     DOI: 10.1016/s0021-9150(99)00021-0

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  10 in total

1.  Association of the CCR2 chemokine receptor gene polymorphism with myocardial infarction.

Authors:  M I Voevoda; S N Ustinov; N S Yudin; M M Dolgikh; T N Kuznetsova; V N Maksimov; I V Kulikov; A A Gromov; A V Shabalin; E V Semaeva; V F Kobzev; S R Baum; V V Gafarov; S K Malyutina; A G Romaschenko; YuP Nikitin
Journal:  Dokl Biol Sci       Date:  2002 Jul-Aug

2.  A three-dimensional in vitro model to demonstrate the haptotactic effect of monocyte chemoattractant protein-1 on atherosclerosis-associated monocyte migration.

Authors:  Neda Ghousifam; Hamid Mortazavian; Rudra Bhowmick; Yolanda Vasquez; Frank D Blum; Heather Gappa-Fahlenkamp
Journal:  Int J Biol Macromol       Date:  2016-12-29       Impact factor: 6.953

3.  Homocysteine stimulates the expression of monocyte chemoattractant protein-1 receptor (CCR2) in human monocytes: possible involvement of oxygen free radicals.

Authors:  G Wang; K O
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

4.  Human endotoxemia induces down-regulation of monocyte CC chemokine receptor 2.

Authors:  Michael Heesen; Rosemarijn Renckens; Alex F de Vos; Dagmar Kunz; Tom van der Poll
Journal:  Clin Vaccine Immunol       Date:  2006-01

5.  Interferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shock.

Authors:  Penny A Rudd; Jane Wilson; Joy Gardner; Thibaut Larcher; Candice Babarit; Thuy T Le; Itaru Anraku; Yutaro Kumagai; Yueh-Ming Loo; Michael Gale; Shizuo Akira; Alexander A Khromykh; Andreas Suhrbier
Journal:  J Virol       Date:  2012-07-03       Impact factor: 5.103

Review 6.  Immunological control of tuberculosis: role of tumour necrosis factor and more.

Authors:  S Stenger
Journal:  Ann Rheum Dis       Date:  2005-11       Impact factor: 19.103

7.  Tumor necrosis factor-α accelerates the resolution of established pulmonary fibrosis in mice by targeting profibrotic lung macrophages.

Authors:  Elizabeth F Redente; Rebecca C Keith; William Janssen; Peter M Henson; Luis A Ortiz; Gregory P Downey; Donna L Bratton; David W H Riches
Journal:  Am J Respir Cell Mol Biol       Date:  2014-04       Impact factor: 6.914

Review 8.  Anti-inflammatory properties of lipid oxidation products.

Authors:  Valery N Bochkov; Norbert Leitinger
Journal:  J Mol Med (Berl)       Date:  2003-09-06       Impact factor: 4.599

9.  Mechanisms of HIV entry into the CNS: increased sensitivity of HIV infected CD14+CD16+ monocytes to CCL2 and key roles of CCR2, JAM-A, and ALCAM in diapedesis.

Authors:  Dionna W Williams; Tina M Calderon; Lillie Lopez; Loreto Carvallo-Torres; Peter J Gaskill; Eliseo A Eugenin; Susan Morgello; Joan W Berman
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

10.  Distinct trans-placental effects of maternal immune activation by TLR3 and TLR7 agonists: implications for schizophrenia risk.

Authors:  Jonathan Cavanagh; Brian J Morris; Jaedeok Kwon; Maria Suessmilch; Alison McColl
Journal:  Sci Rep       Date:  2021-12-13       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.